Menu

Important Document

Important Document

Sr. No. Title Details
151 Hiring of Technical Consultant for Pharmaceuticals and Medical Devices.
152 Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country
153 List of approved applicants under PLI Scheme for Medical Devices
154 Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021
155 Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021
156 List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals
157 List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India
158 Inviting details of local manufacturers of specific medical devices/equipments
159 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
160 Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals
161 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
162 FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof
163 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
164 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
165 Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
166 Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India
167 Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India
168 R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
169 R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
170 Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC).
171 Corrigendum under PLI scheme for Pharmaceuticals
172 Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract.
173 Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.
174 Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices
175 Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013.
176 Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
177 Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg
178 Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country
179 Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
180 Annual Report 2020-21
181 Observing the 7th International Yoga Day, 2021.
182 Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country
183 Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices.
184 Allocation of Tocilizumab Dated 11th May 2021
185 State-wise allocation of Remdesivir vials for period 21st April to 16th May, 2021
186 Revised allocation of Tocilizumab to States
187 State-wise allocation of Remdesivir vials for period 21st April to 9th May, 2021
188 Order dated 25.03.2021 regarding items having sufficient local capacity and local competition as per Para 3(a) of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020
189 Constitution of Internal Complain Committee to prevent Sexual Harassment of Women at workplace in respect of Ministry/Department and the attached/subordinate/ PSUs officers
190 Hiring of 03 Consultants(Non-technical, Grade-II) and 04 Young Professionals as Consultants in Department of Pharmaceuticals on contract basis
191 Action Plan of Swachhata Pakhwada from 1-15 September, 2021
192 List of winners of 6th India Pharma and India Medical Device Awards
193 Detailed Demand for Grants (DDG), Demand No. 7 for the year 2021-22
194 Order dated 16.02.2021 regarding items having sufficient local capacity and local competition as per Para 3(a) of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020
195 Revised Guidelines dated 16.02.2021 for implementing the provisions of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020, related to procurement of Goods and Services in Medical Devices
196 Notice Inviting for Tender -AMC Contract for NPPA Websites
197 Request for Proposals (RFP) document on Selection of Public Financial Institution (Government Company) for providing services of Project Management Agency (PMA) for the implementation of Production Linked Incentive scheme for Pharmaceuticals.
198 Projection of procurement for the next 05 years i.e 2021-22 to 2025-26
199 Advertisement for Selection of the post of Director(Finance), Bengal Chemicals & Pharmaceuticals Ltd. (BCPL), a schedule- C CPSE
200 Corrigendum related to Selection of PMC through RFP under API-CF scheme

Pages